Concepedia

Lucia Festino

LF

Statistics

Publications

21

Citations

1.1K

H-Index

15

Active since

2015

Affiliations

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

National Cancer Institute

Ospedale Santa Chiara

Melanoma Institute Australia

Lucia Festino is an author at Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2015–2023

21

Publications

21

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

Mariaelena Capone, Diana Giannarelli, Domenico Mallardo et al. · Journal for ImmunoTherapy of Cancer · 2018 · 499 citations · Full text

PD-L1 expression as a potential predictive biomarker

Alberto Fusi, Lucia Festino, Gerardo Botti et al. · The Lancet Oncology · 2015 · 114 citations

, , +6

Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy

Nicola Mozzillo, Ester Simeone, Lucia Benedetto et al. · OncoImmunology · 2015 · 83 citations · Full text

Immune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study

Michele Guida, Sabino Strippoli, Milena Maule et al. · ESMO Open · 2021 · 53 citations · Full text

Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy

Roberta Turiello, Mariaelena Capone, Diana Giannarelli et al. · Journal for ImmunoTherapy of Cancer · 2020 · 52 citations · Full text

1–5 of 21